DNA targeting of two new antitumour rebeccamycin derivatives

Author： Facompre M.   Baldeyrou B.   Bailly C.   Anizon F.   Marminon C.   Prudhomme M.   Colson P.   Houssier C.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.37, Iss.12, 2002-12, pp. : 925-932

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular uptake and interaction with purified membranes of rebeccamycin derivatives

By Goossens J.-F.   Henichart J.-P.   Anizon F.   Prudhomme M.   Dugave C.   Riou J.-F.   Bailly C.  

European Journal of Pharmacology, Vol. 389, Iss. 2, 2000-02 ,pp. : 141-146

Elsevier

Access to resources Recommend Favorite

DNA topoisomerase II inhibitors: new approaches to antitumour therapy

By  

Inpharma, Vol. 1, Iss. 1341, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

DNA Tetraplex-Binding Drugs Structure-Selective Targeting is Critical for Antitumour Telomerase Inhibition

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 1, 2001-05 ,pp. : 31-41

Bentham Science Publishers

Access to resources Recommend Favorite

Antitumour Antibiotics with Potent Activity Against Multidrug Resistant (MDR) Staphylococcus aureus: A New Approach to Targeting Resistant Bacteria

By  

Medicinal Chemistry, Vol. 1, Iss. 6, 2005-11 ,pp. : 619-627

Bentham Science Publishers

Access to resources Recommend Favorite

Dimers from dechlorinated rebeccamycin: synthesis, interaction with DNA, and antiproliferative activities

By Marminon C.   Facompre M.   Bailly C.   Hickman J.   Pierre A.   Pfeiffer B.   Renard P.   Prudhomme M.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 5, 2002-05 ,pp. : 435-440

Elsevier

Access to resources Recommend Favorite